Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02584387
Other study ID # 2015-08-0008
Secondary ID
Status Enrolling by invitation
Phase N/A
First received October 20, 2015
Last updated October 25, 2017
Start date September 2016
Est. completion date September 2019

Study information

Verified date October 2017
Source University of Texas at Austin
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study seeks to examine a Virtual Reality Exposure Therapy (VRET) using the 3D Video Virtual Reality (VR) technology for the fear of spiders.


Description:

An estimated 10-11% of the US population experiences a specific phobia at some point in their lives (American Psychiatric Association, 1994; Magee et al., 1996). About 60-85% of those individuals with a specific phobia never seek treatment (Agras, Sylvester, & Oliveau, 1969; Boyd et al., 1990; Magee et al., 1996). Clinical psychologist can help improve the number of phobia sufferers to seek treatment. Advances in technology are helping clinicians create novel treatment strategies for different anxiety disorders. Virtual reality exposure therapy (VRET) may help these individuals confront their fears and treat their phobia.

While virtual reality exposure therapy has shown promise in research (Powers & Emmelkamp, 2008), studies have shown that many users complain that the computer generated virtual reality (VR) stimuli looks unrealistic, eccentric and too much like a video game (Kwon, Powell, & Chalmers, 2013). Virtual reality environments have been traditionally created by programmers using video game assets and computer generated imagery (CGI). While CGI can be used to make intricate virtual environments, unless there is a team of expert digital artists, the virtual stimulus may end up looking rudimentary and exhibit a number of graphical glitches which could prove distracting in therapy. Furthermore CGI often suffers from the uncanny valley effect: the tendency of CGI representations of people to be viewed as unsettling as the representations become more lifelike. In addition the many current CGI virtual reality packages are expensive and only available for limited number of fear domains. Recently however an exciting alternative to traditional computer generated virtual reality has emerged: ortho-stereoscopic 3D Video VR. Ortho-stereoscopic 3D refers to 3D videos that are designed to mimic the natural depth we normally see, as opposed to exaggerating it (i.e. Commercial 3D movies). The benefit of 3D VR as opposed to CGI VR is that it is photo realistic, does not suffer from a uncanny valley effect of CGI, and is able to capture nuances of real life fears that are hard to reproduce with CGI.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 40
Est. completion date September 2019
Est. primary completion date September 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- • Between the ages of 18 and 65

- At least one standard deviation above the SONA pool mean on Fear of Spiders Questionnaire or Acrophobia Questionnaire.

Exclusion Criteria:

- • Hearing or visually impaired where they cannot use the VRET gear

- Currently (or in the last 3 months) receiving exposure-based treatment for acrophobia or arachnophobia

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
3D Video Virtual Reality Exposure Therapy
The 3D video exposure therapy treatment will be administered using an oculus rift virtual reality headset. The oculus rift is a new, affordable virtual reality headset, which uses two different spherical lenses to induce a sense of stereoscopic 3D. Ortho-stereoscopic 3D refers to 3D videos that are designed to mimic the natural depth we normally see, as opposed to exaggerating it (i.e. Commercial 3D movies). To create these 3D videos, the UT 3D Department shot videos of live spiders using a stereoscopic 3D dual camera rig, which simultaneously shoots footage with two cameras positioned apart from each other in a way that mimics the natural pupillary distance between our right and left eyes. To create a sense of 3D depth, the footage of the right and left cameras is then projected on the two different lenses of the oculus rift, creating a sense of depth to the viewer through retinal disparity.

Locations

Country Name City State
United States The University of Texas at Austin Austin Texas

Sponsors (1)

Lead Sponsor Collaborator
University of Texas at Austin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fear of Spiders Questionnaire Pre-treatment and 1 week follow-up
Secondary Behavioral Approach Test Pre-treatment and Post-treatment
Secondary Acceptance and Action Questionnaire Pre-treatment
Secondary State-Trait Anxiety Inventory Pre-treatment
Secondary Anxiety Sensitivity Index (ASI-3) Pre-treatment
Secondary Distress Tolerance Scale (DTS) Pre-treatment
Secondary Disgust Emotion Scale Pre-treatment
Secondary Disgust Propensity and Sensitivity Scale (DPSS-R) Pre-treatment
See also
  Status Clinical Trial Phase
Completed NCT03387254 - Virtual Reality and Brain Stimulation, an Experiential Approach N/A
Completed NCT04737915 - Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights N/A
Recruiting NCT04975854 - Virtual Reality Exposure Therapy for Acrophobia N/A
Completed NCT04620447 - Intelligent Virtual Reality Therapy System and Testing Its Clinical Efficacy Phase 1/Phase 2
Completed NCT05841329 - Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia N/A
Completed NCT05780203 - CBM in the Context of Exposure for Acrophobia N/A
Suspended NCT03917433 - Augmenting Virtual Reality Exposure Therapy for Acrophobia N/A
Not yet recruiting NCT03893214 - Single Session Virtual Reality Therapy in Acrophobia - and the Role of Respiration N/A